Stanley L. Schrier
Dr. Schrier is professor emeritus of medicine in hematology at the Stanford School of Medicine and served as the president of the American Society of Hematology in 2004. Dr. Schrier’s research interests in red cell biology led to a more than 20-year effort to understand the pathophysiology of the thalassemias, with projects in countries with high rates of thalassemia: Israel, Italy, and Thailand.
Dr. Schrier is a founding member of the ASH-supported International Consortium on Acute Leukemia (ICAL), an international network that brings together clinical investigators from Europe, North America, and South America to improve the care of patients with acute leukemia through clinical and laboratory collaboration. He has been a strong supporter and deeply committed member of the network since its inception in 2004, during his term as ASH president. Dr. Schrier was also instrumental in establishing ASH’s partnership with Health Volunteers Overseas (HVO), an outreach program dedicated to bringing consultation and training to hospital personnel in Uganda, Tanzania, Peru, and Cambodia. Dr. Schrier served as chair of the HVO hematology steering committee from 2007 to 2013.
Dr. Schrier has been a dedicated ASH member, as demonstrated by his service as chair and member of various committees including the Committee on Educational Affairs (Member, 1993-2001); Ad Hoc Committee on Outreach (Chair, 2006-2007); and the ASH Executive Committee (President, 2004). In addition to his numerous research and leadership accolades, Dr. Schrier is known as an extraordinary mentor, having trained several world leaders in academic hematology. He received the prestigious ASH Mentor Award in 2013.